Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Voltage-dependent anion-selective channel protein (VDAC) is the most abundant protein in the outer mitochondrial membrane and forms a hydrophilic, voltage-gated pore that enables the exchange of metabolites and ions between the mitochondria and the cytosol[1][2][4]. VDAC exists in three major isoforms in mammals (VDAC1, VDAC2, VDAC3), each with distinct regulatory properties but a conserved β-barrel structure composed of 19 strands[3][4]. The channel is critical for mitochondrial metabolism, apoptosis regulation (by controlling cytochrome c release), and calcium signaling, and it interacts with a wide range of proteins (including hexokinase, Bcl-2 family members, and others)[1][2]. VDACs are considered attractive therapeutic targets for modulating mitochondrial-induced cell death, with implications for cancer therapy and neurodegenerative disorders, but their fundamental role in cellular metabolism presents significant therapeutic challenges and safety considerations[2][4].
Channel blockade to inhibit metabolite and Ca^2+^ flux. Induction of apoptosis via disruption of mitochondrial membrane potential and cytochrome c release. Inhibition/activation of ATP/ADP exchange, affecting cellular energetics. Modulation of ferroptosis by altering redox status or interacting proteins.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Voltage-dependent anion-selective channel protein (VDAC).